Introduction: Diagnostic Criteria for Psychosomatic Research (DCPR) serve as an instrument for identifying and classifying specific psychosomatic syndromes that are not adequately encompassed in standard nosography. The present study aimed at measuring the prevalence of DCPR syndromes in different clinical settings and exploring factors associated to such diagnoses. Methods: A cross-sectional and nationwide study recruited 6,647 patients in different clinical settings: 306 were diagnosed with fibromyalgia (FM), 333 with irritable bowel syndrome, 1,109 with migraine, 2,550 with coronary heart disease (CHD), and 2,349 with type 2 diabetes (T2D). Participants underwent DCPR diagnostic interview and were assessed for depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder 7-Item Scale), and subjective well-being (World Health Organization-5 Well-Being Index). The PsychoSocial Index was used to evaluate global well-being, stress, and abnormal illness behavior. The prevalence of DCPR diagnoses was calculated, and factors associated to such diagnoses were analyzed by logistic regression. Results: Alexithymia (64.47%), irritable mood (20.55%), and demoralization (15.60%) were the most prevalent psychosomatic syndromes, with demoralization being most common in FM (49.02%). The factors associated to DCPR diagnoses encompassed high anxiety or abnormal illness behavior, and poor well-being. Notably, stress was found to be associated specifically to FM and T2D, with OR of 1.24 (95% CI: 1.06–1.46) and 1.26 (95% CI: 1.18–1.36), respectively. Conclusion: DCPR is a clinically helpful complementary assessment tool in need of being widely implemented in clinical settings in order to have a comprehensive picture of the patients.

In the past 10 years, psychosomatic diseases have received increased attention as a leading public health problem. Somatization affects up to 30–40% of internal medicine patients, likely making it the most costly comorbidity [1]. However, their appraisal seems masked by a limited capacity to catch the diagnoses by the standard nosography [2]. Traditional psychiatric classifications such as the DSM have failed to adequately explain the complex interplay between biological and psychological factors in functional somatic syndromes and organic diseases [3, 4]. Although the criteria under “somatic symptom and related disorders” in DSM-5 have undergone significant changes compared to DSM-IV, many psychosomatic symptoms, such as subclinical affective disturbances [5], personality, and behavioral factors, are still not included [6‒8]. On the other hand, the new DSM-5 diagnosis of psychological factors affecting other medical conditions remains vague and lacks specific criteria [9]. DSM is also not well suited to assess the wide range of health behaviors, i.e., how individuals experience, perceive, evaluate, and react to their health status [10‒13].

The Diagnostic Criteria for Psychosomatic Research (DCPR) were proposed by an international group of investigators in 1995 as a complementary tool of assessment with the aim of expanding the traditional domains of the disease model by translating psychosocial variables derived from psychosomatic research into operational tools [14]. DCPR were recently revised [15], with the updated version including also allostatic overload and hypochondriasis. In a variety of clinical settings, DCPR diagnoses were 3.6 times more common than DSM diagnoses [3, 16], and DCPR have proven to be clinically useful in somatic disorders defined by the PFAMC category [17]. The DCPR system has been applied in gastroenterology [18], neurology [19], endocrinology [20], oncology [21], rheumatology [22, 23], cardiology [24], and consultation-liaison psychiatry [25]. They allowed to identify high levels of somatization [26, 27], demoralization [28, 29], allostatic overload [30‒32], and abnormal illness behavior [33], which negatively impact treatment outcomes and health-related quality of life. Alexithymia and persistent somatization, as assessed through the DCPR model, were found as predictors of irritable bowel syndrome (IBS) severity, accounting for 18.5% of the variance [34]. Demoralization identified an additional 20.3% of eating disorder patients not captured by DSM criteria [35]. Additionally, DCPR have more incremental validity than the DSM-5 in explaining an individualʼs psychological states, including well-being, stress, maladaptive illness behavior, and psychological distress (2–24%) [36, 37]. Consequently, there is a necessity to expand the assessment targets of psychiatric evaluation in medically ill patients within the DSM-5 framework [38, 39].

Within this framework, investigating the prevalence rates of DCPR is crucial for obtaining a comprehensive understanding of their occurrence across various clinical settings. Thus, the present research extends this body of work by assessing prevalence in a larger sample. In addition, we examined the multifaceted psychosocial factors influencing DCPR syndromes, an area of research underdeveloped even though it holds significant potential for informing preventive strategies. Patients with fibromyalgia (FM), IBS, migraines, coronary heart disease (CHD), or type 2 diabetes (T2D) were identified as clinical populations in need of been studied since they are often recognized as having psychosomatic components and pose a substantial burden on public health and healthcare systems. We examined DCPR syndromes among subjects with such chronic diseases (i.e., FM, IBS, migraine, CHD, and T2D) to explore (1) DCPR diagnoses prevalence across the five clinical populations, (2) factors associated to a high psychosomatic load (that is, having 3 or more DCPR diagnoses), and (3) psychosocial variables associated with having 3 or more DCPR diagnoses.

Participants

One hundred seventy-five general hospitals across China recruited participants aged 18 to 75 years from May 1, 2022, to December 31, 2023 (online suppl. Fig. S1; for all online suppl. material, see https://doi.org/10.1159/000541404). The sample comprised both outpatients (46.6%) and inpatients (53.4%). The five working groups had a diagnosis of FM, IBS, migraine, CHD, or T2D, respectively. Participants were included based on specific diagnostic criteria. FM had to be diagnosed according to the 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria [40]; IBS according to the Rome IV criteria [41]; migraines by the use of the International Classification of Headache Disorders, 3rd edition (ICHD-3) [42]; the T2D according to the guideline for the prevention and treatment of T2D mellitus (2020 edition) [43]. As what concerns CHD, one of the following diagnoses was made: myocardial infarction; typical angina accompanied by ST-T changes on electrocardiogram during episodes of angina; coronary angiography or coronary CTA demonstrating coronary stenosis >50% or moderate to severe stenosis; coronary stent or balloon dilation and coronary artery bypass grafting. The study exclusion criteria were presence of malignant cancer, occurrence of mental disorders, pregnancy, lactation, cognitive impairment, inability to complete the questionnaires proposed. This nationwide research project received ethical approval from the central institution (Zhongda Hospital, Southeast University, 2021ZDSYLL349-P02). Each participant provided a written consent. All procedures followed the Declaration of Helsinki. The multicenter collaboration employs a hub-and-spoke model.

Instruments

Two senior internists reached a consensus on the diagnoses of the potentially eligible patients according to the established diagnostic criteria for the five diseases. All participants completed a comprehensive questionnaire with the assistance of trained physicians, nurses, or medical students, documenting sociodemographic characteristics (e.g., age, sex, weight, height, marital status, education, working activity, annual family income, smoking, drinking, and living area) and personal clinical history. Subsequently, psychosomatic assessment was conducted using the Semi-Structured Interview for Diagnostic Criteria in Psychosomatic Research-revised [39]. This is a clinimetric tool [33] focusing on the previous 6–12 months and having 79 items with a yes/no answer. It assesses 14 psychosomatic syndromes (i.e., allostatic overload, type A behavior, alexithymia, hypochondriasis, disease phobia, thanatophobia, health anxiety, persistent somatization, conversion symptoms, anniversary reaction, illness denial, demoralization, irritable mood, secondary somatic symptoms) through four diagnostic modules (i.e., stress, personality, illness behavior, psychological manifestation). Since mental disorders were excluded at enrollment, somatic symptoms secondary to a mental disorder were not assessed. The assessment was completed using self-report scales, as mentioned below. The PsychoSocial Index (PSI), a 55-item sensitive index assessing stress and related psychological distress [44], has 12 items that investigate sociodemographic and clinical data and 43 items exploring 5 domains, i.e., stress (items 13–20 and 22–30), well-being (items 31–36), psychological distress (items 37–51), abnormal illness behavior (items 52–54), and quality of life (item 55). Well-being and quality of life can be merged into a global well-being score. Anxiety was measured with the Generalized Anxiety Disorder 7-Item Scale (GAD-7) [45] within the past 2 weeks. Response options for each item range from 0 (“not at all bothered by the problem”) to 3 (“bothered nearly every day”). Depression was measured with the Patient Health Questionnaire (PHQ-9) [46], a nine-item scale designed to evaluate depressive symptoms within the past 2 weeks. Response options for each item range from 0 (“not at all bothered by the problem”) to 3 (“bothered nearly every day”). Subjective well-being was measured via the World Health Organization-5 Well-Being Index (WHO-5) [47], a short, global rating scale comprising five items that encompass fundamental aspects of an individualʼs perception of overall state of well-being. The Chinese versions of DCPR [48], PSI [44], PHQ-9 [46, 49], GAD-7 [50], and WHO-5 [51] were used.

Assessment

Upon initial contact through general hospitals or telephone, interested participants received an information package encompassing general project details, informed consent forms, and questionnaires. The minimum requirement for participation entailed the willingness of individuals to complete the questionnaires. During the screening process, participants were examined for malignant tumors, mental disorders, pregnancy, or lactation to exclude them. This information was collected by self-reporting or medical records. Thereafter, clinical interviews of eligible patients were conducted via an online assessment system. If participants’ age or level of education precluded using electronic devices for evaluation, paper-based instruments were employed and the data were digitized upon completion.

Training and Quality Control

Nationwide, 175 branch center leaders and research assistants underwent training for the project. This training encompassed practicing with the online assessment system and monitoring data quality. For the DCPR, branch center leaders and research assistants were required to attend interview sessions led by trained interviewers. Regarding quality control, the primary center conducts weekly reviews to ensure the accuracy and authenticity of data entry, such as examining inconsistencies in responses or missing scales, regularly monitoring the frequency and patterns of missing data, and addressing potential issues that may lead to incomplete or omitted data. Every 1–2 months, meetings were held to discuss contentious cases or summarize research while maintaining consensus on DCPR diagnoses. Furthermore, to standardize DCPR assessment as much as possible, the main center developed operation manuals and demonstration videos. Consistency evaluations were conducted using simulated patient videos (including a male or a female subject), with inter-rater agreement demonstrated by intraclass correlation coefficients ranging from 0.907 to 1.000.

Online Assessment System and Data Management

Collaboratively developed with software engineering and computer science experts, the online assessment system incorporates the input of five working group leaders and users’ feedback to ensure compatibility with authentic clinical settings. Accessible via electronic devices by scanning QR codes or visiting designated URLs, the platform grants various access levels based on user roles, such as project leaders, working group heads, and researchers. This hierarchical access structure safeguards sensitive data by restricting access to authorized personnel only. The system comprises distinct interfaces for clinicians/researchers and patients, allowing patient data to be input through the patient interface. Simultaneously, each participant is assigned an anonymous identification code. The clinician/researcher interface allows working group leaders to access comprehensive participant information within their specific subcenters. Moreover, the platform implements data validation rules to preclude the entry of logically implausible or improbable values. Digital data were securely uploaded to a central storage server, backed up to tape daily, and archived in at least two locations.

Statistical Analysis

Continuous data are presented as means ± SDs Categorical variables are presented as rates. Multivariable binary logistic regressions were used to evaluate associations of the condition of having 3 or more DCPR among the following psychosocial variables: PHQ-9, GAD-7, WHO-5, PSI. The aim is to compare those with higher psychosomatic load with those with lower one as done in other studies [52]. The analyses were adjusted for age, sex, education, BMI, marital status, working activity, annual family income, smoking status, drinking status, rural residential area. Subsequently, a binary logistic regression model was established for all patients, incorporating the above covariates along with disease type, categorized into five classes: FM, IBS, migraine, CHD, and T2D. Dummy variables were created for each disease type and included in the logistic regression analysis. The advantage of this approach is that multiple disease types and covariates can be considered simultaneously, providing a more comprehensive risk assessment. Collinearity for each covariate in the logistic models was evaluated using the variance inflation factors; there was no evidence of collinearity. The Hosmer-Lemeshow goodness-of-fit test in the multiple logistic regression was performed to assess the model calibration by R package ResourceSelection (version 0.3-6), and calibration curves were plotted.

To examine a possible nonlinear relation between DCPR ≥3 diagnoses and PSI, PHQ-9, or GAD-7 scores, adjusting for age, sex, education, BMI, marital status, working activity, annual family income, smoking status, drinking status, rural residential area, we used restricted cubic splines regression with 4 knots using the rms package (version 6.8-0, https://hbiostat.org/R/rms/) and ggrcs package (version 0.3.8) [53]. When nonlinearity was detected, a recursion algorithm was used to calculate the inflection point of the relationship between the respective variables and DCPR ≥3 diagnoses, respectively, and a two-segment binary logistic regression model was performed on both sides of the inflection point.

Analyses were performed with R, version 4.3.3. p values were two-sided, and a p value <0.05 was considered significant.

Prevalence of DCPR Syndromes

The sample of 7,775 participants included 6,647 (85.5%) with complete data, covering five diseases (online suppl. Table S1). Missing data were sporadic and evenly distributed across populations. The most common diagnoses were alexithymia (64.47%), irritable mood (20.55%), and demoralization (15.60%). The FM group showed the highest rate of demoralization at 49.02%, whereas alexithymia was more prevalent in other clinical groups and the entire sample, with rates between 52.48% and 70.47% (Table 1; online suppl. Fig. S2).

Table 1.

Prevalence of DCPR syndromes in the five clinical populations and in the whole sample

DCPR syndromesTotal (n = 6,647), n (%)FM (n = 306), n (%)IBS (n = 333), n (%)Migraine (n = 1,109), n (%)CHD (n = 2,550), n (%)T2D (n = 2,349), n (%)
Allostatic overload 807 (12.14) 101 (33.01) 39 (11.71) 336 (30.30) 155 (6.08) 176 (7.49) 
Health anxiety 653 (9.82) 35 (11.44) 48 (14.41) 175 (15.78) 139 (5.45) 256 (10.90) 
Disease phobia 411 (6.18) 52 (16.99) 27 (8.11) 126 (11.36) 140 (5.49) 66 (2.81) 
Hypochondriasis 415 (6.24) 62 (20.26) 27 (8.11) 150 (13.53) 120 (4.71) 56 (2.38) 
Thanatophobia 175 (2.63) 7 (2.29) 10 (3.00) 66 (5.95) 75 (2.94) 17 (0.72) 
Illness denial 75 (1.13) 1 (0.33) 6 (1.80) 21 (1.89) 25 (0.98) 22 (0.94) 
Persistent somatization 568 (8.55) 119 (38.89) 42 (12.61) 184 (16.59) 104 (4.08) 119 (5.07) 
Conversion symptoms 68 (1.02) 22 (7.19) 4 (1.20) 19 (1.71) 11 (0.43) 12 (0.51) 
Anniversary reaction 93 (1.40) 14 (4.58) 11 (3.30) 28 (2.52) 17 (0.67) 23 (0.98) 
Demoralization 1,037 (15.60) 150 (49.02) 74 (22.22) 368 (33.18) 239 (9.37) 206 (8.77) 
Demoralization with hopelessness 555 (8.35) 80 (26.14) 33 (9.91) 201 (18.12) 139 (5.45) 102 (4.34) 
Irritable mood 1,366 (20.55) 134 (43.79) 95 (28.53) 471 (42.47) 357 (14.00) 309 (13.15) 
Type a behavior 896 (13.48) 97 (31.70) 49 (14.71) 293 (26.42) 227 (8.90) 230 (9.79) 
Alexithymia 4,285 (64.47) 149 (48.69) 187 (56.16) 582 (52.48) 1,797 (70.47) 1,570 (66.84) 
DCPR syndromesTotal (n = 6,647), n (%)FM (n = 306), n (%)IBS (n = 333), n (%)Migraine (n = 1,109), n (%)CHD (n = 2,550), n (%)T2D (n = 2,349), n (%)
Allostatic overload 807 (12.14) 101 (33.01) 39 (11.71) 336 (30.30) 155 (6.08) 176 (7.49) 
Health anxiety 653 (9.82) 35 (11.44) 48 (14.41) 175 (15.78) 139 (5.45) 256 (10.90) 
Disease phobia 411 (6.18) 52 (16.99) 27 (8.11) 126 (11.36) 140 (5.49) 66 (2.81) 
Hypochondriasis 415 (6.24) 62 (20.26) 27 (8.11) 150 (13.53) 120 (4.71) 56 (2.38) 
Thanatophobia 175 (2.63) 7 (2.29) 10 (3.00) 66 (5.95) 75 (2.94) 17 (0.72) 
Illness denial 75 (1.13) 1 (0.33) 6 (1.80) 21 (1.89) 25 (0.98) 22 (0.94) 
Persistent somatization 568 (8.55) 119 (38.89) 42 (12.61) 184 (16.59) 104 (4.08) 119 (5.07) 
Conversion symptoms 68 (1.02) 22 (7.19) 4 (1.20) 19 (1.71) 11 (0.43) 12 (0.51) 
Anniversary reaction 93 (1.40) 14 (4.58) 11 (3.30) 28 (2.52) 17 (0.67) 23 (0.98) 
Demoralization 1,037 (15.60) 150 (49.02) 74 (22.22) 368 (33.18) 239 (9.37) 206 (8.77) 
Demoralization with hopelessness 555 (8.35) 80 (26.14) 33 (9.91) 201 (18.12) 139 (5.45) 102 (4.34) 
Irritable mood 1,366 (20.55) 134 (43.79) 95 (28.53) 471 (42.47) 357 (14.00) 309 (13.15) 
Type a behavior 896 (13.48) 97 (31.70) 49 (14.71) 293 (26.42) 227 (8.90) 230 (9.79) 
Alexithymia 4,285 (64.47) 149 (48.69) 187 (56.16) 582 (52.48) 1,797 (70.47) 1,570 (66.84) 

FM, fibromyalgia; IBS, irritable bowel syndrome; CHD, coronary heart disease; T2D, type 2 diabetes; DCPR, Diagnostic Criteria for Psychosomatic Research.

Factors Associated with Having at Least Three DCPR Diagnoses

The multivariable logistic regression analyses revealed that higher anxiety or abnormal illness behavior, and poorer global well-being were associated with having at least three DCPR diagnoses in patients with FM, IBS, migraine, CHD, or T2D. Unique risk factors varied among these groups. Stress (FM: OR 1.24, 95% CI: 1.06–1.46, p = 0.009; T2D: OR 1.26, 95% CI: 1.18–1.36, p < 0.001) was significantly associated to DCPR diagnoses in FM and T2Ds (Table 2). Shared factors, including anxiety (GAD-7 scores: OR, 1.14, 95% CI: 1.11–1.17; p < 0.01), abnormal illness behavior (OR: 1.27, 95% CI: 1.20–1.35; p < 0.01), and global well-being (OR: 0.7, 95% CI: 0.66–0.74; p < 0.01) in the whole sample were observed (Table 3). Patients with FM, IBS, and migraine showed to be more prone to have DCPR diagnoses than those with CHD or T2D (online suppl. Table S2). The calibration curves for various patient groups are depicted in online supplementary Figure S3.

Table 2.

Factors associated to having at least three DCPR diagnoses, multivariable logistic regression analysis

VariablesOR (95% CI)p value
Fibromyalgia 
 GAD-7 1.20 (1.12∼1.31) <0.001 
 Stress 1.24 (1.06∼1.46) 0.009 
 Abnormal illness behavior 1.24 (1.04∼1.49) 0.015 
 Global well-being 0.76 (0.63∼0.91) 0.004 
IBS 
 GAD-7 1.18 (1.11∼1.25) <0.001 
 Abnormal illness behavior 1.19 (1.05∼1.34) 0.005 
 Global well-being 0.63 (0.57∼0.70) <0.001 
Migraine 
 GAD-7 1.20 (1.10∼1.31) <0.001 
 Abnormal illness behavior 1.36 (1.07∼1.76) 0.015 
 Global well-being 0.73 (0.60∼0.88) 0.001 
Coronary heart disease 
 Abnormal illness behavior 1.25 (1.14∼1.38) <0.001 
 Global well-being 0.64 (0.58∼0.71) <0.001 
 GAD-7 1.12 (1.07∼1.17) <0.001 
Type 2 diabetes 
 PHQ-9 1.10 (1.05∼1.14) <0.001 
 GAD-7 1.10 (1.05∼1.15) <0.001 
 Stress 1.26 (1.18∼1.36) <0.001 
 Abnormal illness behavior 1.40 (1.25∼1.57) <0.001 
 Global well-being 0.78 (0.71∼0.87) <0.001 
VariablesOR (95% CI)p value
Fibromyalgia 
 GAD-7 1.20 (1.12∼1.31) <0.001 
 Stress 1.24 (1.06∼1.46) 0.009 
 Abnormal illness behavior 1.24 (1.04∼1.49) 0.015 
 Global well-being 0.76 (0.63∼0.91) 0.004 
IBS 
 GAD-7 1.18 (1.11∼1.25) <0.001 
 Abnormal illness behavior 1.19 (1.05∼1.34) 0.005 
 Global well-being 0.63 (0.57∼0.70) <0.001 
Migraine 
 GAD-7 1.20 (1.10∼1.31) <0.001 
 Abnormal illness behavior 1.36 (1.07∼1.76) 0.015 
 Global well-being 0.73 (0.60∼0.88) 0.001 
Coronary heart disease 
 Abnormal illness behavior 1.25 (1.14∼1.38) <0.001 
 Global well-being 0.64 (0.58∼0.71) <0.001 
 GAD-7 1.12 (1.07∼1.17) <0.001 
Type 2 diabetes 
 PHQ-9 1.10 (1.05∼1.14) <0.001 
 GAD-7 1.10 (1.05∼1.15) <0.001 
 Stress 1.26 (1.18∼1.36) <0.001 
 Abnormal illness behavior 1.40 (1.25∼1.57) <0.001 
 Global well-being 0.78 (0.71∼0.87) <0.001 

DCPR, Diagnostic Criteria for Psychosomatic Research; GAD-7, 7-item Generalized Anxiety Disorder; PHQ-9, 9-item Patient Health Questionnaire; OR, odds ratio; IBS, irritable bowel syndrome.

Table 3.

Shared associations with having at least three DCPR diagnoses, multivariable logistic regression analysis in the whole population

VariablesOR (95% CI)p value
Group 
 IBS 1.19 (0.77∼1.86) 0.433 
 Migraine 1.28 (0.89∼1.83) 0.180 
 CHD 0.52 (0.36∼0.74) <0.001 
 T2D 0.63 (0.44∼0.90) 0.012 
PHQ-9 1.05 (1.03∼1.08) <0.001 
GAD-7 1.14 (1.11∼1.17) <0.001 
PSI Stress 1.09 (1.05∼1.13) <0.001 
PSI abnormal illness behavior 1.27 (1.20∼1.35) <0.001 
PSI global well-being 0.70 (0.66∼0.74) <0.001 
VariablesOR (95% CI)p value
Group 
 IBS 1.19 (0.77∼1.86) 0.433 
 Migraine 1.28 (0.89∼1.83) 0.180 
 CHD 0.52 (0.36∼0.74) <0.001 
 T2D 0.63 (0.44∼0.90) 0.012 
PHQ-9 1.05 (1.03∼1.08) <0.001 
GAD-7 1.14 (1.11∼1.17) <0.001 
PSI Stress 1.09 (1.05∼1.13) <0.001 
PSI abnormal illness behavior 1.27 (1.20∼1.35) <0.001 
PSI global well-being 0.70 (0.66∼0.74) <0.001 

DCPR, Diagnostic Criteria for Psychosomatic Research; IBS, irritable bowel syndrome; CHD, coronary heart disease; T2D, type 2 diabetes; PHQ-9, 9-item Patient Health Questionnaire; GAD-7, 7-item Generalized Anxiety Disorder; PSI, PsychoSocial Index.

Association of Psychosocial Scores and DCPR Diagnoses

In online supplementary Figure S4, we used restricted cubic splines to flexibly model and visualize the relationship between various psychosocial scores and the prevalence of having at least three DCPR diagnoses. From online supplementary Figure S4A, as stress scores increase, the risk of having at least three DCPR diagnoses rises (OR = 1.73 for stress ≤5, p for nonlinearity <0.001, 95% CI: 1.65–1.82); however, no significant correlation is observed when the stress scores reach 5 (p = 0.456). The risk increases steadily with higher PHQ-9 scores, peaking at scores below 11 (OR = 1.39 for PHQ-9 <11, 95% CI: 1.35–1.43) and moderates slightly at higher scores (OR = 1.16 for PHQ-9 ≥11, p for nonlinearity <0.001, 95% CI: 1.12–1.20) (online suppl. Fig. S4B). A similar pattern is observed with GAD-7 scores (online suppl. Fig. S4C), where the inflection point is at 7 (OR = 1.53 for GAD-7 <11, p for nonlinearity <0.001, 95% CI: 1.48–1.60). A significant increase in risk is noted for abnormal illness behavior scores <3 (OR = 2.30, p for nonlinearity <0.001, 95% CI: 2.16–2.50), with a diminishing effect as scores exceed this threshold (p for nonlinearity <0.001) (online suppl. Fig. S4D).

A significant psychosomatic burden was found across five clinical populations affected by chronic conditions. Alexithymia, irritable mood, and demoralization were the most prevalent psychosomatic syndromes, with demoralization being most common in FM. Factors specifically associated to DCPR diagnoses were higher anxiety or abnormal illness behavior and poorer global well-being, with distinctive factors such as stress in FM and T2D. Patients with FM, IBS, and migraine were more prone to have DCPR diagnoses compared to those with CHD or T2D. Increasing stress, depression, anxiety, and abnormal illness behavior were significantly associated with higher odds of DCPR risk, with specific thresholds where the effects plateaued or diminished.

This nationwide study offered a unique dataset for examining the prevalence and clinical impact of DCPR syndromes. Some individuals develop alexithymia following traumatic events or physical illness, aligning with the DCPR view of alexithymia as a state condition. Extensive research has established a link between alexithymia and various physical illnesses. The prevalence of alexithymia estimated in our study was higher than that observed in other countries (FM: 33.7–38.2% [22, 54]; CHD: 37%) [55]. One explanation might be rooted in the cultural context of China. Traditional Chinese culture often emphasizes emotional restraint and collectivism, which can discourage expressing and recognizing of personal emotions [56, 57]. Another possible explanation may be the rapid socioeconomic changes in China over the past few decades that have introduced significant stressors, including urbanization, occupational pressures, lifestyle changes, which challenged mental health [58‒60]. Irritable mood was prevalent in our sample. Substantial evidence suggests a pathogenic role for anger, hostility, and irritable mood in physical diseases [61], particularly cardiovascular ones [62, 63]. Irritable mood is related to increased gray matter volume in the orbitofrontal cortex [64] and heightened activity in the amygdala and hypothalamus [65] as well as to increased monoamine transmission [66, 67], contributing to its connection with anxiety and depression. Using DCPR to identify irritable mood can assist in neurological research and treatment development, potentially predicting response to certain medications [68].

The distinctive clinical symptoms of FM differentiate it from other groups, where alexithymia is the predominant DCPR diagnosis. Consistently with previous research, about 50% of FM patients experienced demoralization [22]. The core symptom of FM, chronic widespread pain, often leads to frustration, helplessness, and hopelessness [69, 70]. The unpredictability of pain and the perceived lack of control over its management may also exacerbate these negative emotional states, resulting in demoralization. Subjective incompetence is considered a clinical hallmark of demoralization [29, 71], and when hopelessness and helplessness become pervasive and persistent, they may evolve into clinical depression that can, in turn, amplify the perception of pain [72]. As previous research has found, demoralization as a response to chronic stress is associated with various features, including allostatic overload [73]. It also diminishes quality of life, mediated by depressive symptoms [74], and is linked to poor euthymia [35], which include well-being [75].

The present findings showed a significant association between anxiety and abnormal illness behavior and an elevated risk of psychosomatic symptoms. These results build upon existing evidence that anxiety frequently results in heightened awareness and negative interpretation of bodily sensations [76] and that abnormal illness behavior intensifies frustration with medical experiences [77, 78], especially in patients presenting with three or more DCPR diagnoses (OR = 2.3). In contrast, well-being showed a protective role against DCPR diagnoses. Higher well-being is likely to bolster resilience to stress [79], thereby mitigating the risk of psychosomatic symptoms. This finding underscores the importance of incorporating the assessment of positive emotions and well-being into clinical evaluations, particularly under the light of the emerging evidence on interventions promoting well-being, such as well-being therapy [39, 80], which ultimately fosters a balance among psychic forces, resilience, and euthymia [75].

Distinctive factors associated with DCPR diagnoses revealed the complex interplay with chronic conditions. Prior research has noted a notable prevalence of psychosomatic syndromes in individuals with FM [22, 54]. Our study builds upon this by demonstrating that stress plays a significant role in the likelihood of individuals with FM receiving a DCPR diagnosis, particularly in those with three or more diagnoses compared to those with fewer. Chronic stress may worsen pain sensitivity and psychological symptoms by influencing the neuroendocrine system, such as the HPA axis, and immune responses [81]. Furthermore, individuals with FM demonstrate impairment in the default mode network and the amygdala [82], mirroring observations in posttraumatic stress disorder [83, 84]. These findings are consistent with our investigation, which revealed a 33% prevalence of allostatic overload, signifying that (chronic) stress may surpass the body ability to cope, exacerbating symptoms.

The large transdiagnostic sample findings showed a pronounced proneness to psychosomatic symptoms among patients with FM, IBS, or migraine compared to those with CHD or T2D. This phenomenon can be attributed to several underlying factors. First, the pathophysiological mechanisms of FM, IBS, and migraine are closely linked to central sensitization and heightened stress responses [85‒88]. Second, the chronic pain and discomfort characteristic of FM, IBS, and migraines can lead to heightened awareness and reporting of psychosomatic symptoms. This is consistent with earlier studies linking functional disorders to higher psychological distress [89, 90].

Several studies demonstrated that stress, abnormal illness behavior, depression, and anxiety exacerbate psychosomatic symptoms in chronic disease patients. The present results extend beyond the evidence that increased stress significantly correlates with higher DCPR risk up to a score of 5 (OR = 1.73). Patients with at least three DCPR diagnoses showed to be 2.3 times more likely to exhibit abnormal illness behavior within the 0–3 score range than those with less than three DCPR diagnoses. These thresholds guide the creation of focused interventions that enhance resource allocation according to clinical attributes.

The mentioned results should be considered under the light of several limitations. The DCPR assessment was done at 175 subcenters. Therefore, the possibility of variation between subcenters exists. However, all participating subcenters completed a standardized assessment process before the study, and stringent quality control procedures were used during the study. Second, the patients were recruited at tertiary level clinics and may, therefore, represent the most severe groups. Female subjects in FM, IBS, and migraine were overrepresented, but such sex imbalance mirrors the clinical realm that is characterized by higher prevalence and incidence of these diseases among females than males [91‒93]. Additionally, exclusion criteria were identified via self-reports or medical records, potentially underestimating mental disorders and cognitive impairment. Finally, the cross-sectional design of the study makes any inference of a causal relationship between DCPR syndromes and predictors weak.

The present study proved the clinical utility of running an assessment via the use of DCPR in diverse clinical settings. In addition, it suggests that anxiety, abnormal illness behavior, and well-being should be recognized as factors associated with DCPR diagnoses. At a clinical level, identifying the DCPR diagnoses and associated factors, which may impact treatment outcomes, can enhance cliniciansʼ understanding of patientsʼ characteristics. This knowledge can aid in identifying care paths for patients who need complex interventions under the light of the biopsychosocial model [94]. At a research level, investigating analogous phenomena to prevent ambiguity and identifying key factors of DCPR diagnoses can facilitate the advancement of innovative interventions tailored to address the vulnerabilities associated with each psychosomatic condition.

We thank the Chinese Psychosomatic Medicine Association, the collaborators, and the participants for their time, support, and effort. Special thanks are extended to the DCPRs-C Working Group for their significant contributions to the investigation and data collection. A detailed list of its members is in the online supplementary material.

This nationwide research project received ethical approval from the central institution (Zhongda Hospital, Southeast University, 2021ZDSYLL349-P02). Each participant provided a written informed consent.

The authors have no conflicts of interest to declare.

This project was partially supported by the National Natural Science Foundation of China (Grant No. 81971277, Yonggui Yuan) and the Jiangsu Provincial Key Research and Development Program (Grant No. BE2019748, Yonggui Yuan).

W.X.: project administration, data curation, formal analysis, methodology, writing – original draft, and writing – review and editing; W.H.J.: project administration, formal analysis, methodology, and writing – review and editing; Y.Y.Y.: conceptualization, methodology, and resources; R.J.D., H.T., Y.Y.W., Y.P.T., D.F.L., Y.P.W., and M.W.W.: project administration, methodology, supervision, and investigation; B.W.C.: methodology and formal analysis; Y.Y.K.: resources and software; L.L.T. and L.Y.: investigation and data curation; F.C.: conceptualization, project administration, methodology, formal analysis, supervision, and writing – review and editing; Y.G.Y.: conceptualization, project administration, funding acquisition, methodology, supervision, and writing – review and editing; and on behalf of the DCPRs-C Working Group: investigation and data curation.

Additional Information

Wei Xu and Wenhao Jiang should be considered as the co-first authors to this work.Fiammetta Cosci and Yonggui Yuan should be considered as the co-senior authors to this work.

The datasets generated and/or analyzed for the current study contain clinical data and are not publicly available due to the protection of participants’ rights to privacy and data protection. Further inquiries can be directed to the corresponding author.

1.
Kellner
R
.
Somatization: the most costly comorbidity?
In:
Maser
JD
,
Cloninger
CR
, editors.
Comorbidity of mood and anxiety disorders
.
American Psychiatric Press
;
1990
. p.
239
52
.
2.
Fava
GA
,
Patierno
C
,
Sonino
N
,
Cosci
F
.
Key psychosocial issues in medical care
.
Acta Psychiatr Scand
.
2024
;
149
(
5
):
368
77
.
3.
Fava
GA
,
Sonino
N
,
Wise
TN
.
The psychosomatic assessment. Strategies to improve clinical practice
. In:
Advances in Psychosomatic Medicine
.
2012
.
Vol. 32
. p.
108
17
.
4.
Feczko
E
,
Miranda-Dominguez
O
,
Marr
M
,
Graham
AM
,
Nigg
JT
,
Fair
DA
.
The heterogeneity problem: approaches to identify psychiatric subtypes
.
Trends Cogn Sci
.
2019
;
23
(
7
):
584
601
.
5.
Hanel
G
,
Henningsen
P
,
Herzog
W
,
Sauer
N
,
Schaefert
R
,
Szecsenyi
J
, et al
.
Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study
.
J Psychosom Res
.
2009
;
67
(
3
):
189
97
.
6.
Sirri
L
,
Fabbri
S
,
Fava
GA
,
Sonino
N
.
New strategies in the assessment of psychological factors affecting medical conditions
.
J Pers Assess
.
2007
;
89
(
3
):
216
28
.
7.
Mewes
R
.
Recent developments on psychological factors in medically unexplained symptoms and somatoform disorders
.
Front Public Health
.
2022
;
10
:
1033203
.
8.
Maj
M
.
Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them
.
World Psychiatr
.
2018
;
17
(
2
):
121
2
.
9.
Sykes
R
.
Somatoform disorder and the DSM-V workgroup’s interim proposals: two central issues
.
Psychosomatics
.
2012
;
53
(
4
):
334
8
.
10.
Kasl
SV
,
Cobb
S
.
Health behavior, illness behavior, and sick role behavior. I. Health and illness behavior
.
Arch Environ Health
.
1966
;
12
(
2
):
246
66
.
11.
Mechanic
D
.
Sociological dimensions of illness behavior
.
Soc Sci Med
.
1995
;
41
(
9
):
1207
16
.
12.
Fava
GA
,
Cosci
F
,
Sonino
N
,
Guidi
J
.
Understanding health attitudes and behavior
.
Am J Med
.
2023
;
136
(
3
):
252
9
.
13.
Wise
TN
.
Illness denial in medical conditions: the time has come to include it in DSM iterations
.
Psychother Psychosom
.
2023
;
92
(
5
):
292
4
.
14.
Fava
GA
,
Freyberger
HJ
,
Bech
P
,
Christodoulou
G
,
Sensky
T
,
Theorell
T
, et al
.
Diagnostic criteria for use in psychosomatic research
.
Psychother Psychosom
.
1995
;
63
:
1
8
.
15.
Fava
GA
,
Cosci
F
,
Sonino
N
.
Current psychosomatic practice
.
Psychother Psychosom
.
2017
;
86
(
1
):
13
30
.
16.
Porcelli
P
,
Rafanelli
C
.
Criteria for psychosomatic research (DCPR) in the medical setting
.
Curr Psychiatry Rep
.
2010
;
12
(
3
):
246
54
.
17.
Guidi
J
,
Rafanelli
C
,
Roncuzzi
R
,
Sirri
L
,
Fava
GA
.
Assessing psychological factors affecting medical conditions: comparison between different proposals
.
Gen Hosp Psychiatry
.
2013
;
35
(
2
):
141
6
.
18.
Gostoli
S
,
Ferrara
F
,
Quintavalle
L
,
Tommasino
S
,
Gigante
G
,
Montecchiarini
M
, et al
.
Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD)
.
BMC Psychol
.
2024
;
12
(
1
):
211
.
19.
Zhu
B
,
Kohn
R
,
Patel
A
,
Koo
BB
,
Louis
ED
,
de Figueiredo
JM
.
Demoralization and quality of life of patients with Parkinson disease
.
Psychother Psychosom
.
2021
;
90
(
6
):
415
21
.
20.
Sonino
N
,
Fava
GA
,
Lucente
M
,
Guidi
J
.
Allostatic load and endocrine disorders
.
Psychother Psychosom
.
2023
;
92
(
3
):
162
9
.
21.
Grassi
L
,
Sabato
S
,
Rossi
E
,
Biancosino
B
,
Marmai
L
.
Use of the diagnostic criteria for psychosomatic research in oncology
.
Psychother Psychosom
.
2005
;
74
(
2
):
100
7
.
22.
Tesio
V
,
Ghiggia
A
,
Di Tella
M
,
Castelli
L
.
Utility of the Diagnostic Criteria for Psychosomatic Research in assessing psychological disorders in fibromyalgia patients
.
J Affect Disord
.
2019
;
256
:
219
20
.
23.
Leombruni
P
,
Zizzi
F
,
Pavan
S
,
Fusaro
E
,
Miniotti
M
.
Allostatic overload in patients with fibromyalgia: preliminary findings
.
Psychother Psychosom
.
2019
;
88
(
3
):
180
1
.
24.
Gostoli
S
,
Bonomo
M
,
Roncuzzi
R
,
Biffi
M
,
Boriani
G
,
Rafanelli
C
.
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD)
.
Int J Cardiol
.
2016
;
220
:
360
4
.
25.
Porcelli
P
,
Bellomo
A
,
Quartesan
R
,
Altamura
M
,
Iuso
S
,
Ciannameo
I
, et al
.
Psychosocial functioning in consultation-liaison psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization
.
Psychother Psychosom
.
2009
;
78
(
6
):
352
8
.
26.
Mangelli
L
,
Bravi
A
,
Fava
GA
,
Ottolini
F
,
Porcelli
P
,
Rafanelli
C
, et al
.
Assessing somatization with various diagnostic criteria
.
Psychosomatics
.
2009
;
50
(
1
):
38
41
.
27.
Porcelli
P
,
Guidi
J
.
The clinical utility of the diagnostic criteria for psychosomatic research: a review of studies
.
Psychother Psychosom
.
2015
;
84
(
5
):
265
72
.
28.
Woźniewicz
A
,
Cosci
F
.
Clinical utility of demoralization: a systematic review of the literature
.
Clin Psychol Rev
.
2023
;
99
:
102227
.
29.
Fava
GA
,
Guidi
J
.
Clinical characterization of demoralization
.
Psychother Psychosom
.
2023
;
92
(
3
):
139
47
.
30.
Pfaltz
MC
,
Schnyder
U
.
Allostatic load and allostatic overload: preventive and clinical implications
.
Psychother Psychosom
.
2023
;
92
(
5
):
279
82
.
31.
Mansueto
G
,
Romanazzo
S
,
Romaniello
C
,
Guiducci
S
,
Galimberti
S
,
Cosci
F
.
Allostatic overload in the medically ill patients: results from an observational study
.
JCBP
.
2024
;
2
:
2758
.
32.
Cosci
F
,
Svicher
A
,
Mansueto
G
,
Benemei
S
,
Chiarugi
A
,
De Cesaris
F
, et al
.
Mental pain and pain-proneness in patients with migraine: results from the PAINMIG cohort-study
.
CNS Spectr
.
2020
;
26
(
5
):
491
500
.
33.
Piolanti
A
,
Gostoli
S
,
Gervasi
J
,
Sonino
N
,
Guidi
J
.
A trial integrating different methods to assess psychosocial problems in primary care
.
Psychother Psychosom
.
2019
;
88
(
1
):
30
6
.
34.
Porcelli
P
,
De Carne
M
,
Leandro
G
.
Distinct associations of DSM-5 somatic symptom disorder, the diagnostic criteria for psychosomatic research-revised (DCPR-R) and symptom severity in patients with irritable bowel syndrome
.
Gen Hosp Psychiatry
.
2020
;
64
:
56
62
.
35.
Tecuta
L
,
Fava
GA
,
Tomba
E
.
An innovative approach for the assessment of mood disturbances in patients with eating disorders
.
CNS Spectr
.
2020
;
25
(
1
):
71
8
.
36.
Guidi
J
,
Piolanti
A
,
Berrocal
C
,
Gostoli
S
,
Carrozzino
D
.
Incremental validity of the diagnostic criteria for psychosomatic research - revised (DCPR-R) to clinical assessment in primary care
.
Psychiatry Res
.
2020
;
291
:
113233
.
37.
Cosci
F
,
Svicher
A
,
Romanazzo
S
,
Maggini
L
,
De Cesaris
F
,
Benemei
S
, et al
.
Criterion-related validity in a sample of migraine outpatients: the diagnostic criteria for psychosomatic research
.
CNS Spectr
.
2020
;
25
(
4
):
545
51
.
38.
Fava
GA
,
Guidi
J
,
Porcelli
P
,
Rafanelli
C
,
Bellomo
A
,
Grandi
S
, et al
.
A cluster analysis-derived classification of psychological distress and illness behavior in the medically ill
.
Psychol Med
.
2012
;
42
(
2
):
401
7
.
39.
Guidi
J
,
Fava
GA
.
The clinical science of euthymia: a conceptual map
.
Psychother Psychosom
.
2022
;
91
(
3
):
156
67
.
40.
Wolfe
F
,
Clauw
DJ
,
Fitzcharles
M-A
,
Goldenberg
DL
,
Häuser
W
,
Katz
RL
, et al
.
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria
.
Semin Arthritis Rheum
.
2016
;
46
(
3
):
319
29
.
41.
Lacy
BE
,
Mearin
F
,
Chang
L
,
Chey
WD
,
Lembo
AJ
,
Simren
M
, et al
.
Bowel disorders
.
Gastroenterology
.
2016
;
150
(
6
):
1393
407.e5
.
42.
Headache classification committee of the international Headache Society (IHS) the international classification of headache disorders, 3rd edition
.
Cephalalgia
.
2018
;
38
(
1
):
1
211
.
43.
Zhu
D
,
Society
CD
.
Guideline for the prevention and treatment of type 2 diabetes mellitus in China: 2020 edition
.
Zhonghua Tang Niao Bing Za Zhi
.
2021
;
13
:
315
409
.
44.
Piolanti
A
,
Offidani
E
,
Guidi
J
,
Gostoli
S
,
Fava
GA
,
Sonino
N
.
Use of the psychosocial index: a sensitive tool in research and practice
.
Psychother Psychosom
.
2016
;
85
(
6
):
337
45
.
45.
Spitzer
RL
,
Kroenke
K
,
Williams
JBW
,
Löwe
B
.
A brief measure for assessing generalized anxiety disorder: the GAD-7
.
Arch Intern Med
.
2006
;
166
(
10
):
1092
7
.
46.
Kroenke
K
,
Spitzer
RL
,
Williams
JB
.
The PHQ-9: validity of a brief depression severity measure
.
J Gen Intern Med
.
2001
;
16
(
9
):
606
13
.
47.
Topp
CW
,
Østergaard
SD
,
Søndergaard
S
,
Bech
P
.
The WHO-5 Well-Being Index: a systematic review of the literature
.
Psychother Psychosom
.
2015
;
84
(
3
):
167
76
.
48.
Huang
W-L
,
Liao
S-C
.
Psychometric properties of the Chinese version of the diagnostic criteria for psychosomatic research
.
Psychother Psychosom
.
2017
;
86
(
2
):
119
20
.
49.
Yu
X
,
Tam
WWS
,
Wong
PTK
,
Lam
TH
,
Stewart
SM
.
The Patient Health Questionnaire-9 for measuring depressive symptoms among the general population in Hong Kong
.
Compr Psychiatry
.
2012
;
53
(
1
):
95
102
.
50.
He
X
,
Li
C
,
Qian
J
,
Cui
H
,
Wu
W
.
Reliability and validity of a generalized anxiety disorder scale in general hospital outpatients (article in Chinese)
.
Shanghai Arch Psychiatry
.
2010
;
22
:
200
3
.
51.
Fung
S-F
,
Kong
CYW
,
Liu
Y-M
,
Huang
Q
,
Xiong
Z
,
Jiang
Z
, et al
.
Validity and psychometric evaluation of the Chinese version of the 5-item WHO well-being index
.
Front Public Health
.
2022
;
10
:
872436
.
52.
Venditti
F
,
Cosci
F
,
Bernini
O
,
Berrocal
C
.
Criterion validity of the diagnostic criteria for psychosomatic research in patients with morbid obesity
.
Psychother Psychosom
.
2013
;
82
(
6
):
411
2
.
53.
Andersen
PK
,
Harrell
FE
.
Regression modeling strategies with applications to linear models, logistic regression and survival analysis
.
Springer-Verlag
:
New York
;
2001
.
Vol. 22
. p.
2531
2
.
54.
Ghiggia
A
,
Torta
R
,
Tesio
V
,
Di Tella
M
,
Romeo
A
,
Colonna
F
, et al
.
Psychosomatic syndromes in fibromyalgia
.
Clin Exp Rheumatol
.
2017
;
35 Suppl 105
(
3
):
106
11
.
55.
Beresnevaité
M
,
Taylor
GJ
,
Bagby
RM
.
Assessing alexithymia and type A behavior in coronary heart disease patients: a multimethod approach
.
Psychother Psychosom
.
2007
;
76
(
3
):
186
92
.
56.
Parker
G
,
Gladstone
G
,
Chee
KT
.
Depression in the planet’s largest ethnic group: the Chinese
.
Aust J Pharm
.
2001
;
158
(
6
):
857
64
.
57.
Chen
X
,
Comunian
AL
,
Gielen
UP
.
Growing up in a collectivist culture: socialization and socioemotional development in Chinese children
. In:
International perspectives on human development
.
Pabst Science Publishers
;
2000
.
58.
Gong
P
,
Liang
S
,
Carlton
EJ
,
Jiang
Q
,
Wu
J
,
Wang
L
, et al
.
Urbanisation and health in China
.
Lancet
.
2012
;
379
(
9818
):
843
52
.
59.
Chen
H
,
Liu
Y
,
Li
Z
,
Xue
D
.
Urbanization, economic development and health: evidence from China’s labor-force dynamic survey
.
Int J Equity Health
.
2017
;
16
(
1
):
207
.
60.
Sun
Y
,
Bao
Y
,
Ravindran
A
,
Sun
Y
,
Shi
J
,
Lu
L
.
Mental health challenges raised by rapid socioeconomic transformations in China
.
Heart and Mind
.
2020
;
4
(
3
):
59
66
.
61.
Fava
GA
.
Irritable mood and physical illness
.
Stress Med
.
1987
;
3
(
4
):
293
9
.
62.
Julkunen
J
,
Salonen
R
,
Kaplan
GA
,
Chesney
MA
,
Salonen
JT
.
Hostility and the progression of carotid atherosclerosis
.
Psychosom Med
.
1994
;
56
(
6
):
519
25
.
63.
Anderer
S
.
New research could help explain anger’s link to heart attacks and strokes
.
JAMA
.
2024
;
331
(
24
):
2065
6
.
64.
Besteher
B
,
Squarcina
L
,
Spalthoff
R
,
Bellani
M
,
Gaser
C
,
Brambilla
P
, et al
.
Brain structural correlates of irritability: findings in a large healthy cohort
.
Hum Brain Mapp
.
2017
;
38
(
12
):
6230
8
.
65.
Yu
R
,
Mobbs
D
,
Seymour
B
,
Rowe
JB
,
Calder
AJ
.
The neural signature of escalating frustration in humans
.
Cortex
.
2014
;
54
:
165
78
.
66.
Jha
MK
,
Minhajuddin
A
,
South
C
,
Rush
AJ
,
Trivedi
MH
.
Irritability and its clinical utility in major depressive disorder: prediction of individual-level acute-phase outcomes using early changes in irritability and depression severity
.
Aust J Pharm
.
2019
;
176
(
5
):
358
66
.
67.
Yamamoto
K
,
Shinba
T
,
Yoshii
M
.
Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view
.
Psychiatry Clin Neurosci
.
2014
;
68
:
1
20
.
68.
Bell
E
,
Boyce
P
,
Porter
RJ
,
Bryant
RA
,
Malhi
GS
.
Irritability in mood disorders: neurobiological underpinnings and implications for pharmacological intervention
.
CNS Drugs
.
2021
;
35
(
6
):
619
41
.
69.
Sarzi-Puttini
P
,
Giorgi
V
,
Marotto
D
,
Atzeni
F
.
Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
.
Nat Rev Rheumatol
.
2020
;
16
(
11
):
645
60
.
70.
Palomino
RA
,
Nicassio
PM
,
Greenberg
MA
,
Medina
EP
.
Helplessness and loss as mediators between pain and depressive symptoms in fibromyalgia
.
Pain
.
2007
;
129
(
1–2
):
185
94
.
71.
Cockram
CA
,
Doros
G
,
de Figueiredo
JM
.
Diagnosis and measurement of subjective incompetence: the clinical hallmark of demoralization
.
Psychother Psychosom
.
2009
;
78
(
6
):
342
5
.
72.
Berna
C
,
Leknes
S
,
Holmes
EA
,
Edwards
RR
,
Goodwin
GM
,
Tracey
I
.
Induction of depressed mood disrupts emotion regulation neurocircuitry and enhances pain unpleasantness
.
Biol Psychiatry
.
2010
;
67
(
11
):
1083
90
.
73.
Porcelli
P
,
Laera
D
,
Mastrangelo
D
,
Di Masi
A
.
Prevalence of allostatic overload syndrome in patients with chronic cardiovascular disease
.
Psychother Psychosom
.
2012
;
81
(
6
):
375
7
.
74.
Tang
L
,
Li
Z
,
Pang
Y
.
The differences and the relationship between demoralization and depression in Chinese cancer patients
.
Psychooncology
.
2020
;
29
(
3
):
532
8
.
75.
Guidi
J
,
Fava
GA
.
The emerging role of euthymia in psychotherapy research and practice
.
Clin Psychol Rev
.
2020
;
82
:
101941
.
76.
Asmundson
GJG
,
Katz
J
.
Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art
.
Depress Anxiety
.
2009
;
26
(
10
):
888
901
.
77.
Drossman
DA
,
Chang
L
,
Deutsch
JK
,
Ford
AC
,
Halpert
A
,
Kroenke
K
, et al
.
A review of the evidence and recommendations on communication skills and the patient-provider relationship: A Rome foundation working team report
.
Gastroenterology
.
2021
;
161
(
5
):
1670
88.e7
.
78.
Kellner
R
.
Hypochondriasis and somatization
.
JAMA
.
1987
;
258
(
19
):
2718
22
.
79.
Strauss
C
,
Gu
J
,
Montero-Marin
J
,
Whittington
A
,
Chapman
C
,
Kuyken
W
.
Reducing stress and promoting well-being in healthcare workers using mindfulness-based cognitive therapy for life
.
Int J Clin Health Psychol
.
2021
;
21
(
2
):
100227
.
80.
Fava
GA
.
Well-being therapy, treatment manual and clinical applications
.
Karger Publishers
;
2016
.
81.
Gupta
A
,
Silman
AJ
.
Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link
.
Arthritis Res Ther
.
2004
;
6
(
3
):
98
106
.
82.
Serafini
RA
,
Pryce
KD
,
Zachariou
V
.
The mesolimbic dopamine system in chronic pain and associated affective comorbidities
.
Biol Psychiatry
.
2020
;
87
(
1
):
64
73
.
83.
Mahan
AL
,
Ressler
KJ
.
Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder
.
Trends Neurosci
.
2012
;
35
(
1
):
24
35
.
84.
Zhang
Y
,
Wu
W
,
Toll
RT
,
Naparstek
S
,
Maron-Katz
A
,
Watts
M
, et al
.
Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography
.
Nat Biomed Eng
.
2021
;
5
(
4
):
309
23
.
85.
Staud
R
.
Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome
.
Arthritis Res Ther
.
2006
;
8
(
3
):
208
.
86.
Erdrich
S
,
Hawrelak
JA
,
Myers
SP
,
Harnett
JE
.
A systematic review of the association between fibromyalgia and functional gastrointestinal disorders
.
Therap Adv Gastroenterol
.
2020
;
13
:
1756284820977402
.
87.
Brennan
KC
,
Pietrobon
D
.
A systems neuroscience approach to migraine
.
Neuron
.
2018
;
97
(
5
):
1004
21
.
88.
Akerman
S
,
Karsan
N
,
Bose
P
,
Hoffmann
JR
,
Holland
PR
,
Romero-Reyes
M
, et al
.
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity
.
Brain
.
2019
;
142
(
1
):
103
19
.
89.
Kato
K
,
Sullivan
PF
,
Evengård
B
,
Pedersen
NL
.
A population-based twin study of functional somatic syndromes
.
Psychol Med
.
2009
;
39
(
3
):
497
505
.
90.
Rometsch
C
,
Mansueto
G
,
Maas Genannt Bermpohl
F
,
Martin
A
,
Cosci
F
.
Prevalence of functional disorders across Europe: a systematic review and meta-analysis
.
Eur J Epidemiol
.
2024
;
39
(
6
):
571
86
.
91.
Heidari
F
,
Afshari
M
,
Moosazadeh
M
.
Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis
.
Rheumatol Int
.
2017
;
37
(
9
):
1527
39
.
92.
Lovell
RM
,
Ford
AC
.
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis
.
Clin Gastroenterol Hepatol
.
2012
;
10
(
7
):
712
21.e4
.
93.
Agosti
R
.
Migraine burden of disease: from the patient’s experience to a socio-economic view
.
Headache
.
2018
;
58
(
Suppl 1
):
17
32
.
94.
Engel
GL
.
The need for a new medical model: a challenge for biomedicine
.
Science
.
1977
;
196
(
4286
):
129
36
.